Shocker! PE-Backed Deal Value Actually Grew during First Half of 2012: Slideshow of the Year’s Biggest Deals
Deal value for PE-backed transactions actually increased during the first half of this year, according to data from Thomson Reuters.
That’s not the case with general M&A. So far this year, we’ve seen 3,627 U.S. announced mergers during the first half of 2012, valued at $333.9 billion, Thomson Reuters said. First half’s deal value dropped nearly 41% from the 4,339 transactions that totaled $565.7 billion for the same time period in 2011.
One of the year’s biggest deals is the sale of Pfizer Nutrition to Nestle for nearly $12 billion.
Private equity-backed M&A (which includes LBOs and acquisitions made by portfolio companies) wasn’t as depressing. In fact, deal value jumped by 5%. There were 688 deals valued at $56.3 billion during the first half of 2012, compared to 733 transactions totaling $53.6 billion, Thomson Reuters said. Some may scoff at this meager 5% increase, but with deals as slow as they are, I’ll take what I can get.
What were the biggest PE-backed deals so far this year? Well, you’ll have to read the rest to find out.
Photo courtesy of Shutterstock
Last month, Chesapeake said it was selling its limited partner units and general partner interests in Chesapeake Midstream Partners LP to Global Infrastructure Partners. The deal was valued at $2 billion.